Detalhe da pesquisa
1.
Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study.
Kardiol Pol
; 81(11): 1089-1095, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997824
2.
Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study).
Pol Arch Intern Med
; 132(6)2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293200
3.
Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.
Int J Environ Res Public Health
; 19(8)2022 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35457747